| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,193 |
1,394 |
$243K |
| Q9991 |
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
253 |
139 |
$225K |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
219 |
125 |
$207K |
| 99354 |
|
688 |
395 |
$54K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
732 |
457 |
$18K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
676 |
429 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,345 |
281 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
372 |
122 |
$7K |
| 99215 |
Prolong outpt/office vis |
301 |
174 |
$6K |
| 80305 |
|
218 |
121 |
$3K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
20 |
17 |
$349.86 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
217 |
182 |
$271.42 |
| 96373 |
|
14 |
12 |
$63.12 |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
13 |
12 |
$0.00 |